Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Repomia 6000IU

Prescription Icon
Prescription Required

Marketer

Biokindle Lifesciences Pvt Ltd

Salt Composition

Recombinant Human Erythropoietin Alfa (6000IU)

Overview Repomia 6000IU

ErythroGen 6000IU is a medication that stimulates red blood cell production within the bone marrow. Its primary application is in treating anemia stemming from kidney dysfunction. It's also indicated for anemia resulting from cancer chemotherapy or antiretroviral therapy for HIV. ErythroGen 6000IU is administered via injection, either subcutaneously or intravenously, as determined by your physician. Injections are typically given by a healthcare professional. Dosage is tailored to your weight and the underlying cause of your anemia. Concurrent iron supplementation, both before and during treatment, may enhance its efficacy. ErythroGen 6000IU requires refrigeration but should reach room temperature before administration. Commonly reported side effects include nausea, vomiting, fever, and elevated blood pressure. Flu-like symptoms such as headache, fatigue, dizziness, and myalgia are also possible, often subsiding after the initial treatment phase. Persistent side effects should be discussed with your doctor; they may suggest management strategies. Report severe adverse reactions immediately, particularly seizures. Serious thromboembolic events are a potential complication requiring prompt medical attention. Before commencing ErythroGen 6000IU treatment, inform your doctor of any uncontrolled hypertension, cardiovascular disease, or gout. Disclose all other medications you are taking, as interactions may occur. Regular blood pressure monitoring is essential during treatment. Additional routine testing may be necessary to monitor for potential adverse effects. The medication's impact on fetal development is currently unknown; inform your doctor if you are pregnant, intend to become pregnant, or are breastfeeding.

Primary Ingredients of Repomia 6000IU

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Repomia 6000IU

Managing Anemia in Cancer Chemotherapy Patients | Addressing Anemia in Chronic Kidney Disease

Major Benefits of Repomia 6000IU:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Repomia 6000IU:

  • High blood pressure
  • Nausea
  • Vomiting
  • Fever
  • Rash
  • Joint pain
  • Headache
  • Insomnia (difficulty in sleeping)
  • Chills
  • Cough
  • Bone pain
  • Muscle spasm
  • Dizziness
  • Vascular occlusion
  • Injection site irritation
  • Stomatitis (Inflammation of the mouth)
  • Weight loss
  • Decreased white blood cell count (lymphocytes)
  • Increased glucose level in blood
  • Blood clot in the blood vessels

How to use Repomia 6000IU:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Repomia 6000IU works:

Repomia 6000IU, an erythropoiesis stimulant, boosts red blood cell production by prompting increased activity within the bone marrow, the blood cell-forming tissue residing within bones.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Repomia 6000IU's interaction with alcohol is currently undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Repomia 6000IU during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Repomia 6000IU while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Repomia 6000IU, which can produce adverse reactions.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Repomia 6000IU without requiring a dosage alteration. However, routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Repomia 6000IU. Dosage modification of Repomia 6000IU might be necessary. Physician consultation is advised.

What if you forget to take Repomia 6000IU :

Omitting a scheduled dose of Repomia 6000IU necessitates contacting your physician.

Facts to Know About Repomia 6000IU

LabelValue
Chemical Category Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Repomia 6000IU

Hospital-stored Repomia 6000IU pre-filled syringes remain unopened and refrigerated (2-8°C). For home use, refrigerate the syringe (not freeze it), allowing it to reach room temperature (15-30 minutes) before administration. Used or soon-to-be-used syringes may be kept at room temperature (below 25°C) for up to 7 days. Keep out of reach of children and protect from light.
Inform your doctor or nurse immediately if you suspect an overdose of Repomia 6000IU.
Do not use Repomia 6000IU if the solution is cloudy, contains particles, or is expired (check the label). Avoid use if you suspect freezing or refrigeration failure.
Repomia 6000IU treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects in children are comparable to those seen in adults.
Repomia 6000IU can influence blood pressure. Monitor blood pressure during treatment; patients with hypertension should manage their condition appropriately. Discontinuation of Repomia 6000IU may be necessary if blood pressure remains uncontrolled.
Repomia 6000IU
1,941
MRP 2,140
9% off